Immuneering's total assets for Q1 2025 were $50.68B, an increase of 96043.15% from the previous quarter. IMRX total liabilities were $8.84B for the fiscal quarter, a 77921.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.